Barchart on MSN10h
Here's What to Expect From Quest Diagnostics’ Next Earnings Report
Valued at a market cap of $18.2 billion, Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the ...
FMIBlog14h
Global Personal Genome Testing Market Projected to Reach USD 4,468 Million by 2032 amid Soaring Demand for Personalized Healthcare Solutions | FMI
The global personal genome testing market is on a remarkable growth trajectory, projected to soar to USD 4,468 million by 2032, up from USD 1,545.5 million in 2022. This growth reflects a robust CAGR ...
360Dx3d
Proscia Using $50M Fundraise to Expand Staff, Bolster AI Tools Menu
The firm said that investors provided better-than-expected backing as the company anticipates growing use of its digital pathology platform in 2025.
StockStory.org on MSN4d
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including ...
Quest Diagnostics initiated with a Buy at Redburn Atlantic
Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...
Digi Power Reports 115% Quarterly Revenue Growth in Q1 2025, Maintains Debt-Free Operations and Strengthens Cash Position
The Company’s total aggregate Q1 2025 revenue of approximately $12.1 million (based on a BTC price of $83,500 as of March 31, 2025, per CoinMarketCap) represents an increase in quarterly revenue of ...